Molnar I. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.. (1991) ACTA MEDICA HUNGARICA 0236-5286 48 1-2 13-21,
2568543
Szakcikk (Folyóiratcikk) | Tudományos[2568543]
ARNOLD K et al. IMMUNOGLOBULIN-A CLASS FIBROBLAST ANTIBODIES IN PATIENTS WITH GRAVES-DISEASE AND PRETIBIAL MYXEDEMA.. (1995) JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 0021-972X 1945-7197 80 12 3430-3437
Tandon N et al. IMMUNOGLOBULIN CLASS AND SUBCLASS DISTRIBUTION OF EYE MUSCLE AND FIBROBLAST ANTIBODIES IN PATIENTS WITH THYROID-ASSOCIATED OPHTHALMOPATHY. (1994) CLINICAL ENDOCRINOLOGY 0300-0664 1365-2265 40 629-639
Molnár I et al. Anti-thyroid antibodies and hypothyroidism in systemic sclerosis. (1992) JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 0391-4097 1720-8386 15 4 p. 311,
1019192
Rövid közlemény (Folyóiratcikk) | Tudományos[1019192]
Solanki Kamal K et al. High Prevalence of Antithyroid Antibodies in a New Zealand Cohort of Patients With Systemic Sclerosis. (2018) JCR : JOURNAL OF CLINICAL RHEUMATOLOGY 1076-1608 1536-7355 24 5 264-271
Posselt Rayana Taques et al. Prevalence of thyroid autoantibodies in patients with systematic autoimmune rheumatic diseases. Cross-sectional study. (2017) SAO PAULO MEDICAL JOURNAL 1516-3180 135 6 535-540
Antonelli A et al. Fatigue in patients with systemic sclerosis and hypothyroidism. A review of the literature and report of our experience. (2017) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 0392-856X 1593-098X 35 S193-S197
Arif T et al. Does systemic sclerosis affect thyroid functions? A study upholding association. (2017) JOURNAL OF PAKISTAN ASSOCIATION OF DERMATOLOGISTS 1560-9014 27 1 4-9
Singh Pawan Kumar et al. Can thyroid volume predict thyroid dysfunction in patients with systemic sclerosis? A prospective cross-sectional study from a tertiary care center in North West India. (2016) CLINICAL RHEUMATOLOGY 0770-3198 1434-9949 35 3 765-769
Toki Sayaka et al. Demographic and clinical features of autoimmune thyroid disorder in Japanese patients with systemic sclerosis. (2014) JOURNAL OF DERMATOLOGY 0385-2407 1346-8138 41 12 1053-1057
Danielides S et al. Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma. (2011) SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 0300-9742 1502-7732 40 4 299-303
Antonelli A et al. Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. (2007) EUROPEAN JOURNAL OF ENDOCRINOLOGY 0804-4643 1479-683X 156 4 431-437
Molnár I et al. Evaluation of thyroid function and anti-thyroid autoantibodies in systemic sclerosis. (1992) ACTA DERMATO-VENEREOLOGICA 0001-5555 1651-2057 72 112-115,
1019189
Szakcikk (Folyóiratcikk) | Tudományos[1019189]
Fallahi Poupak et al. Associations between Systemic Sclerosis and Thyroid Diseases. (2017) FRONTIERS IN ENDOCRINOLOGY 1664-2392 8
Marasini B et al. Thyroid dysfunction in women with systemic sclerosis. (2007) Megjelent: AUTOIMMUNITY, PT D - AUTOIMMUNE DISEASE, ANNUS MIRABILIS pp. 305-311
Twining JM et al. The incidence of serologic evidence of antecedent autoimmune thyroiditis in asymptomatic patients referred to an outpatient rheumatology consultation clinic for a positive antinuclear antibody test. (2007) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 0392-856X 1593-098X 25 3 502-503
Rövid közlemény (Folyóiratcikk) | Tudományos[21262389] [Admin láttamozott]
Nakamura H et al. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjogren's syndrome. (2006) TRANSLATIONAL RESEARCH 1931-5244 1878-1810 148 6 281-288
Ozgen AG et al. Hypothalamus-hypophysis-thyroid axis, triidothyronine and antithyroid antibodies in patients with primary and secondary Sjogren's syndrome. (2001) CLINICAL RHEUMATOLOGY 0770-3198 1434-9949 20 1 44-48
Molnar I. The relationship between anti-human eye muscle antibodies and thyroid function, anti-TSH receptor antibodies and eye symptoms in Graves' ophthalmopathy.. (1992) WIENER KLINISCHE WOCHENSCHRIFT: MIDDLE EUROPEAN JOURNAL OF MEDICINE 0043-5325 1613-7671 104 24 744-747,
2568540
Szakcikk (Folyóiratcikk) | Tudományos[2568540]
Pichler R et al. Enterovirusinfektion - Ein möglicher auslöser der Basedowschen krankheit? | [Enterovirus infection - A possible trigger for Graves' disease?]. (2001) WIENER KLINISCHE WOCHENSCHRIFT: MIDDLE EUROPEAN JOURNAL OF MEDICINE 0043-5325 1613-7671 113 5-6 204-207
Molnar I et al. TSH binding site structures in human eye muscle fractions identified by using covalent-crosslinking. (1992) BIOMEDICINE & PHARMACOTHERAPY 0753-3322 1950-6007 46 2-3 121-125,
2568539
Rövid közlemény (Folyóiratcikk) | Tudományos[2568539]
Rapoport B et al. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. (1998) ENDOCRINE REVIEWS 0163-769X 1945-7189 19 6 673-716
MENGISTU M et al. TSH RECEPTOR GENE-EXPRESSION IN RETROOCULAR FIBROBLASTS. (1994) JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 0391-4097 1720-8386 17 6 437-441
JAUME JC et al. THYROTROPIN RECEPTOR AUTOANTIBODIES RECOGNIZING 2 DIFFERENT EPITOPES ON THE TSH RECEPTOR - LACK OF RELATIONSHIP TO PATIENT AGE, SEX, AND OPHTHALMOPATHY. (1993) THYROID 1050-7256 1557-9077 3 4 291-295
HEUFELDER AE et al. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves ophthalmopathy and pretibial dermopathy.. (1993) THYROID 1050-7256 1557-9077 3 4 297-300
Czirják L et al. Anti platelet antibodies against gpIIb/IIIa in systemic sclerosis. (1994) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 0392-856X 1593-098X 12 5 527-529,
1019270
Rövid közlemény (Folyóiratcikk) | Tudományos[1019270]
Scherlinger Marc et al. The role of platelets in immune-mediated inflammatory diseases. (2023) NATURE REVIEWS IMMUNOLOGY 1474-1733 1474-1741
Frasca L. et al. Toll-like receptors in mediating pathogenesis in systemic sclerosis. (2020) CLINICAL AND EXPERIMENTAL IMMUNOLOGY 0009-9104 1365-2249 201 1 14-24
Scherlinger Marc et al. Systemic lupus erythematosus and systemic sclerosis: All roads lead to platelets. (2018) AUTOIMMUNITY REVIEWS 1568-9972 1873-0183 17 6 625-635
Solanilla A et al. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis. (2009) RHEUMATOLOGY (UNITED KINGDOM) 1462-0324 1462-0332 48 9 1036-1044
Postlethwaite AE et al. Platelet contributions to the pathogenesis of systemic sclerosis. (2007) CURRENT OPINION IN RHEUMATOLOGY 1040-8711 1531-6963 19 6 574-579
Chiang TM et al. Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis. (2006) THROMBOSIS RESEARCH 0049-3848 1879-2472 117 3 299-306
Sicińska J et al. Raynaud's disease and Raynaud's phenomenon in connective tissue diseases: Choroba Raynauda i objaw Raynauda w przebiegu kolagenoz. (2002) POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE 0032-3772 1897-9483 108 4 1011-1022
Wulffraat NM et al. Atypical juvenile generalized scleroderma presenting as polyarthritis and failure to thrive. (1998) BRITISH JOURNAL OF RHEUMATOLOGY 0263-7103 37 2 222-227
Balazs C. In vitro suppression of anti-TSH receptor antibody by autologous anti-idiotypic antibody in patients with Graves' disease.. (1995) ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA 1217-8950 1588-2640 42 2 163-169,
2568535
Szakcikk (Folyóiratcikk) | Tudományos[2568535]
Hampe CS. Protective role of anti-idiotypic antibodies in autoimmunity - Lessons for type 1 diabetes .. (2012) AUTOIMMUNITY 0891-6934 1607-842X 45 4 320-331
Terryberry JW Shoenfeld et al. Detection of antibodies to gangliosides and glycolipids in various intravenous immunoglobulin (IVIg) preparations.. (2000) IMMUNOLOGICAL INVESTIGATIONS 0882-0139 1532-4311 29 3 337-347
Kaczur V. Kinetic characterization of thyroid peroxidase enzyme and its inhibition by autoantibodies.. (1995) ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA 1217-8950 1588-2640 42 4 345-350,
2568534
Szakcikk (Folyóiratcikk) | Tudományos[2568534]
Skopek E et al. Detection of autoantibodies against thyroid peroxidase in serum samples of hypothyroid dogs. (2006) AMERICAN JOURNAL OF VETERINARY RESEARCH 0002-9645 1943-5681 67 5 809-814
Molnar I et al. IgA autoantibodies against human eye muscle antigen detected by western blotting and immunohistochemical methods in Graves' disease.. (1995) JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 0391-4097 1720-8386 18 6 408-414,
2568533
Szakcikk (Folyóiratcikk) | Tudományos[2568533]
Le Moli R et al. Graves' orbitopathy: Extraocular muscle/total orbit area ratio is positively related to the clinical activity score. (2012) EUROPEAN JOURNAL OF OPHTHALMOLOGY 1120-6721 1724-6016 22 3 301-308
Mizokami T et al. Eye muscle antibodies in Graves' ophthalmopathy: Pathogenic or secondary epiphenomenon?. (2004) JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 0391-4097 1720-8386 27 2 221-229
Grus FH et al. Analysis of the IgG autoantibody repertoire in endocrine ophthalmopathy using the MegaBlot technique.. (1998) CURRENT EYE RESEARCH 0271-3683 1460-2202 17 6 636-641
Molnar I. Detectable serum IgE levels in Graves' ophthalmopathy.. (1996) EUROPEAN JOURNAL OF MEDICAL RESEARCH 0949-2321 1 11 543-546,
2568532
Szakcikk (Folyóiratcikk) | Tudományos[2568532]
Virakul S et al. Histamine induces NF-κB controlled cytokine secretion by orbital fibroblasts via histamine receptor type-1. (2016) EXPERIMENTAL EYE RESEARCH 0014-4835 1096-0007 147 85-93
Virakul S et al. Platelet-derived growth factor-BB enhances adipogenesis in orbital fibroblasts. (2015) INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE 0146-0404 1552-5783 56 9 5457-5464
Chong KK et al. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children .: 49 (6) , pp. 2409-2415. (2008) INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE 0146-0404 1552-5783 49 6 2409-2415
Hiromatsu Y et al. Interleukin-13 gene polymorphisms confer the susceptibility of Japanese populations to Graves' disease .. (2005) JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 0021-972X 1945-7197 90 1 296-301
Kubota S et al. Effect of high dose methylprednisolone pulse therapy followed by oral prednisolone administration on the production of anti-TSH receptor antibodies and clinical outcome in Graves' disease.. (2005) ENDOCRINE JOURNAL 0918-8959 1348-4540 52 6 735-741
Bednarczuk T et al. Interleukin-13 gene polymorphisms in patients with Graves' disease.. (2003) CLINICAL ENDOCRINOLOGY 0300-0664 1365-2265 59 4 519-525
Durrani Khayyam et al. Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease.. (2011) SURVEY OF OPHTHALMOLOGY 0039-6257 1879-3304 56 6 474-510
YUE Chengchun. Efficacy of pentoxifylline and prednisone in the treatment of ocular diseases in Graves’ disease.. (2008) CHINESE JOURNAL OF MISDIAGNOSTICS 1009-6647 8 19 4579-4580
TANG Jian. Progress in research on human leukocyte antigen DR and thyroid associated ophthalmopathy.. (2004) SICHUAN MEDICAL JOURNAL 1004-0501 25 10 1142-1144
Wang J et al. Immunosuppressive therapies in patients with Graves' ophthalmopathy. (2004) CHINESE JOURNAL OF INTEGRATIVE MEDICINE 1672-0415 1993-0402 43 2 125-127
Wang Jian Wang. Therapeutic outcomes of mycophenolate mofetil and three other immunosuppressants in patients with Graves' ophthalmopathy. (2003) JOURNAL OF MEDICAL POSTGRADUATES / YIXUE YANJIUSHENG XUEBAO 1008-8199 16 12 p. 15
Nagy Z et al. Suppressive effect of pentoxifylline on natural killer cell activity; experimental and clinical studies. (1999) NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 0028-1298 1432-1912 359 3 228-234
Balazs C et al. Beneficial effect of pentoxifylline on thyroid associated ophthalmopathy (TAO)*: a pilot study.. (1997) JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 0021-972X 1945-7197 82 6 1999-2002,
2568530
Szakcikk (Folyóiratcikk) | Tudományos[2568530]
Akbarian Shadi et al. A Systematic Review on the Role of Antioxidants in Thyroid Eye Disease. (2022) JOURNAL OF CURRENT OPHTHALMOLOGY 2452-2325 34 1 16-24
Hwang Sena et al. Inhibitory effects of α-lipoic acid on oxidative stress-induced adipogenesis in orbital fibroblasts from patients with Graves' ophthalmopathy. (2016) MEDICINE 0025-7974 1536-5964 95 2 1-8
Yoon Jin et al. Cigarette smoke extract-induced adipogenesis in Graves' orbital fibroblasts is inhibited by quercetin via reduction in oxidative stress. (2013) JOURNAL OF ENDOCRINOLOGY 0022-0795 1479-6805 216 2 145-156
Feelders RA et al. The burden of Cushing's disease: Clinical and health-related quality of life aspects. (2012) EUROPEAN JOURNAL OF ENDOCRINOLOGY 0804-4643 1479-683X 167 3 311-326
Ye Xiaozhen et al. Oxidative stress and Graves' ophthalmopathy.. (2012) GUOJI NEIFENMI DAIXIE ZAZHI / INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM 1726-913X 1726-9148 4 1 65-67
Genol Saavedra et al. Estrés oxidativo y orbitopatía de Graves Oxidative stress and Graves\' orbitopathy: [Oxidative stress and graves orbitopathy]. (2012) ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA 0365-6691 1989-7286 87 8 235-236
Marcocci Claudio et al. Selenium and the course of mild Graves' orbitopathy.. (2011) NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 1533-4406 364 20 1920-1931
Marcocci Claudio et al. Effect of selenium on the course of mild forms of Graves ophthalmopathy.. (2011) INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 1687-8337 1687-8345 5 37 17-31
Madaschi Sara et al. Treatment of thyroid-associated orbitopathy with rituximab-a novel therapy for an old disease: case report and literature review.. (2010) ENDOCRINE PRACTICE 1530-891X 1934-2403 16 4 677-685
Dalmatova AB. Treatment of Graves' ophthalmopathy. (2010) KLINICHESKAYA I EKSPERIMENTALNAYA TIREOIDOLOGIYA / CLINICAL AND EXPERIMENTAL THYROIDOLOGY 1995-5472 6 3 16-23
Salvi M et al. Management of mild graveś orbitopathy. (2010) Megjelent: Graves' Orbitopathy: A Multidisciplinary Approach - Questions and Answers pp. 111-119
Hondur Ahmet et al. Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy.. (2008) CURRENT EYE RESEARCH 0271-3683 1460-2202 33 5-6 421-427
De Almeida CA et al. Clinical evaluation of the long-term response to intravenous pulses of methylprednisolone in patients with moderate to severe Graves ophthalmopathy. (2006) ENDOCRINOLOGIST 1051-2144 16 4 193-196
Claudio Marcocci. Current medical management of Thyroid Orbitopathy.. (2005) Megjelent: Orbital disease. Present status and future challenges. pp. 261-273
Bartalena L et al. An update on medical management of Graves' ophthalmopathy. (2005) JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 0391-4097 1720-8386 28 5 469-478
Finamor FE et al. Pentoxifylline (PTX) - An alternative treatment in Graves' ophthalmopathy (inactive phase): Assessment by a disease specific quality of life questionnaire and by exophthalmometry in a prospective randomized trial. (2004) EUROPEAN JOURNAL OF OPHTHALMOLOGY 1120-6721 1724-6016 14 4 277-283
Marcocci C et al. Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy. (2004) JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 0391-4097 1720-8386 27 3 272-280
Ajjan RA et al. New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy. (2004) JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 0391-4097 1720-8386 27 3 237-245
Bartalena L et al. Graves' ophthalmopathy: State of the art and perspectives. (2004) JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 0391-4097 1720-8386 27 3 295-301
Bartalena Luigi. Novel approaches to the management of graves' ophthalmopathy.. (2002) HORMONES: OFFICIAL JOURNAL OF THE EUROPEAN ASSOCIATION OF ENDOCRINOLOGY 0367-617X 0018-5051 1 76-90
Bartalena Luigi. Management of thyroid eye disease.. (2002) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 1619-7070 1619-7089 29 2 S458-S465
Wiersinga Wilmar et al. Graves' ophthalmopathy: a rational approach to treatment.. (2002) TRENDS IN ENDOCRINOLOGY AND METABOLISM 1043-2760 1879-3061 13 7 280-287
Marcocci Claudio et al. Current medical management of Graves ophthalmopathy.. (2002) OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY 0740-9303 1537-2677 18 6 402-408
Krassas GE Heufelder. Immunosuppressive therapy in patients with thyroid eye disease: an overview of current concepts.. (2001) EUROPEAN JOURNAL OF ENDOCRINOLOGY 0804-4643 1479-683X 144 4 311-318
Huang W. Current situation and prospect of Graves ophthalmopathy treatment. (2001) GUOJI YANKE ZONGLAN / FOREIGN MEDICAL SCIENCES (OPHTHALMOLOGY) (CHINA) 1001-1196 1673-5803 21 6 317-319